Atrion

Atrion Corp. engages in the manufacture and development of products for medical applications. It offers products for cardiovascular, fluid delivery, and ophthalmic. It also offers contract manufacturing and kitting services, and marine & aviation inflation components. The company was founded in 1944 and is headquartered in Allen, TX.

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Atrion Corporation is a supplier of medical devices and components to niche markets in the health care and medical industry. Atrion's proprietary products, ranging from cardiovascular and ophthalmology products to fluid delivery devices, are sold to end-users, distributors and other manufacturers worldwide. As a developer and manufacturer of a diverse range of products, Atrion stays on the forefront of technology and manufacturing with products that meet the needs of its targeted markets.

Atrion Corp ( ATRI , Financial), a leading player in the Medical Devices & Instruments industry, is currently trading at $557 per share. The company has a market capitalization of $980.596 million and has seen a stock price gain of 4.7% today.

Atrion Corp (ATRI): A Medical Device Stock with Good Outperformance Potential

Agilent Technologies

Agree Realty

Ameren

Federal Agricultural

Albemarle

Allstate

Allegion

Air Products and Chemicals

Alexandria Real Estate Equities

Broadcom

Axis Capital

Bank of America

Booz Allen Hamilton Hld

Brookfield Asset Management

BancFirst

Baxter

Becton, Dickinson and Co.

Franklin Resources

Brookfield Renewable Partners

Bank of Nova Scotia

Cadence Bank

Cardinal Health

Crown Castle International

A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates.

Dividend Champion, Contender, And Challenger Highlights: Week Of June 25

Atrion Corporation has traded within a wide range over the past 6 months with little-to-no major catalysts. There appear to be market-generated reasons for this, rather than fundamental changes.

Atrion: Trading Below Value, Volatility Presents Mispricings

ALLEN, Texas, May 08, 2023 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) today announced its results for the first quarter ended March 31, 2023.

Atrion Reports First Quarter 2023 Results

Amphenol

BWX Technologies

C.H. Robinson Worldwide

A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends.

Dividend Champion, Contender, And Challenger Highlights: Week Of March 26

Arbor Realty Trust

AGCO

Albany International

Assurant

Arthur J. Gallagher & Co.

Air Lease

Alerus Financial Corp

Applied Materials

American National Bankshares

Arrow Financial

Associated Banc-Corp

Ashland Global Hlds

Avista

Avnet

Avery Dennison

Armstrong World Industries

Brunswick

Bar Harbor Bankshares

Dividend Champion, Contender, And Challenger Highlights: Week Of March 12

ALLEN, Texas, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) today announced its results for the fourth quarter ended December 31, 2022 and the full year 2022.

Atrion Reports Fourth Quarter and Full Year 2022 Results

Record third quarter revenue, with upsides observed across the product portfolio. Strong return on capital coupled with free cash outflows, a key finding that pulled through from previous analysis.

Atrion: Fair And Reasonably Priced For Resiliency Premium

ALLEN, Texas, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) today announced its results for the third quarter ended September 30, 2022.

Atrion Reports Third Quarter 2022 Results

Artrion Corp. looks well positioned to continue delivering stable, predictable future cash flows. The stock is ideal for those seeking defensive characteristics into equity portfolios.

Atrion: Attractively Priced For Exposure To Defensive Healthcare

ALLEN, Texas, Aug. 25, 2022 (GLOBE NEWSWIRE) -- Atrion Corporation. (NASDAQ: ATRI) today announced that its Board of Directors has approved a succession plan under which Cindy Ferguson, currently the Company's Controller, will become the Company's Vice President and Chief Financial Officer, Secretary, and Treasurer effective March 4, 2023, succeeding Jeffery Strickland, who currently holds those positions and whose retirement effective March 3, 2023 has been previously reported.

Atrion Corporation Announces CFO Succession Plan

ALLEN, Texas, Aug. 22, 2022 (GLOBE NEWSWIRE) -- Atrion Corporation (Nasdaq ATRI) today announced an increase in its quarterly cash dividend from $1.95 per share to $2.15 per share. Specifically, the Board of Directors declared a quarterly cash dividend of $2.15 per share on its outstanding shares of Common Stock. This dividend will be payable on September 30, 2022 to stockholders of record at the close of business on September 15, 2022.

Atrion Corporation Increases Quarterly Cash Dividend by 10%

ALLEN, Texas, Aug. 08, 2022 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) today announced its results for the second quarter ended June 30, 2022.

Atrion Reports Second Quarter 2022 Results

ALLEN, Texas, May 09, 2022 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) today announced its results for the first quarter ended March 31, 2022.

Atrion Reports First Quarter 2022 Results

ALLEN, Texas, Feb. 25, 2022 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) today announced its results for the fourth quarter ended December 31, 2021 and the full year 2021.

Atrion Reports Fourth Quarter and Full Year 2021 Results

ALLETE

Bristol-Myers

Cass Information Systems

Gilead Sciences

Kimberly-Clark

L3Harris

Merck

Sempra Energy

This monthly series ranks a selection of dividend growth stocks in Dividend Radar and presents the ten top-ranked stocks for consideration. To rank stocks, I use DVK Quality Snapshots to obtain quality scores, sort them in descending order, and break ties with additional metrics.

10 Dividend Growth Stocks For December 2021

ALLEN, Texas, Nov. 08, 2021 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) today announced its results for the third quarter ended September 30, 2021.

Atrion Reports Third Quarter Results

Accenture Plc

Automatic Data Processing

Andersons

Algonquin Power & Utilities

Artesian Resources

Brookfield Infrastructure Partners L.P.

Bank of South Carolina

C&F Financial

A weekly summary of dividend activity for Dividend Champions and Contenders.

Dividend Champion And Contender Highlights: Week Of September 26

ChoiceOne Financial Services Inc

Capital Southwest

First Republic

New Jersey Resources

Verizon

This article series covers dividend changes. A table with relevant data and key statistics of dividend increases is provided.

Dividend Increases: August 28-September 10, 2021

ALLEN, Texas, Aug. 30, 2021 (GLOBE NEWSWIRE) -- Atrion Corporation (Nasdaq ATRI) today announced an increase in its quarterly cash dividend from $1.75 per share to $1.95 per share. Specifically, the Board of Directors declared a quarterly dividend of $1.95 per share on its outstanding shares of Common Stock. This dividend will be payable on September 30, 2021 to stockholders of record at the close of business on September 15, 2021.

Atrion Corporation Increases Quarterly Cash Dividend by 11%

ALLEN, Texas, Aug. 09, 2021 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) today announced that for the second quarter ended June 30, 2021, revenues totaled $42.7 million compared with $38.0 million for the same period in 2020. Net income for the second quarter of 2021 totaled $8.9 million as compared to $8.6 million for the same period in 2020, with diluted earnings per share for the second quarter of 2021 at $4.88 compared to $4.68 for the second quarter of 2020.

Atrion Reports Second Quarter Results

Capital City Bank Group

Employers Hlds

FNCB Bancorp

First National Corp. (Strasburg, VA)

Huntington Ingalls Industries

Hawthorn Bancshares

Macatawa Bank

Marten Transport

Summit Financial Group

Small- and mid-cap stocks tend to outperform large-cap peers due to their small size. In this article, I will look for the most undervalued small- and mid-cap stocks from the CCC list.

Dividend Growing Small- And Mid-Cap Companies Watchlist

ALLEN, Texas, May 10, 2021 (GLOBE NEWSWIRE) -- Atrion Corporation (Nasdaq - ATRI) today announced that revenues for the quarter ended March 31, 2021 were $39.2 million compared with $43.6 million for the first quarter of 2020. Net income in the current-year quarter totaled $7.7 million compared to $8.9 million in last year's first quarter, with diluted earnings per share for the first quarter of 2021 at $4.22 compared to $4.79 for the first quarter of 2020.

Atrion Reports First Quarter Results

ALLEN, Texas, Feb. 26, 2021 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) announced today that for the fourth quarter of 2020 revenues were $32.2 million compared to $34.5 million in the same period of 2019, net income was $7.4 million compared to $8.1 million in the prior year period, and diluted earnings per share were $4.02 compared to $4.33 in the prior-year period. For the full year 2020 compared to 2019, Atrion revenues declined to $147.6 million from $155.1 million, net income was $32.1 million compared to $36.8 million, and diluted earnings per share were $17.44 compared to $19.73.

Atrion Reports Results for Fourth Quarter and Full Year 2020

Atrion is a long-term value creator which has lost a third of its value over the past eighteen months. This correction should be seen in the light of the long-term share price developments, as the company continued to see steady growth.

Atrion: A Potential Healthy Addition To The Portfolio

News for Atrion Stock (ATRI)